GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a lona protease domain in complex with bortezomib

Analyse Crystal structure of a lona protease domain in complex with bortezomib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4YPM
Type
protein
Length
290 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lon protease
EC
3.4.21.53
UniProt
A0A059VAZ3
Ligands
BO2, MG
Pockets
1 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALon protease (EC 3.4.21.53)protein29044% helix, 21% strandA0A059VAZ3

Ligands and binding sites

  • BO2 · N-[(1R)-1-(dihydroxyboryl)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A
  • CIT · Citric acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1830.450.8126BO2

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4YPM · Crystal structure of a LonA protease domain in complex with bortezomib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.